ACTRN12622000472774撤回未知
Assessment of the efficacy of closed loop technology for glucose control in young children with Type 1 Diabetes
适应症
试验速览
- 阶段
- 未知
- 状态
- 撤回
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 2 Years 至 7 Years（—）
- 性别
- All
入选标准
- •1.Type 1 diabetes (diagnosis consistent with American Diabetes Association Classification of Diabetes Mellitus, diagnosed at least 1 year ago)
- •2.CSII therapy for at least 3 months
- •3.Age 2 to 7 years (inclusive)
- •4.Total daily insulin of greater or equal 8 units/day in last 2 weeks
- •5.Participant and parent willing to follow study instructions
- •6.Living in an area with internet and cellular coverage
排除标准
- •1. Commenced CGM in the 3 months prior to screening visit
- •2. Using advanced hybrid closed loop system: Control IQ
- •3. Uncontrolled coeliac disease
- •4. Uncontrolled thyroid disease
- •5. Inability or unwillingness to meet protocol requirements
- •6. Unwilling to perform 3 to 4 finger stick blood glucose measurements daily
- •7. Use of Hydroxyurea medication
- •8. Poor vision (of primary caregiver) precluding the use of investigational technology
研究者
相似试验
已完成
不适用
Closed Loop In Pregnancy: normal daily activities studyNutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusType 1 diabetesISRCTN50385583Cambridge University Hospital NHS Foundation Trust (UK)12
已完成
不适用
Efficacy and safety of a novel closure method Loop9 for mucosal defect after Colorectal Endoscopic submucosal dissectioColorectal tumorsJPRN-UMIN000046253Showa University Koto Toyosu Hospital100
招募中
Unknown
The effect of clinical guidelines on the care performance of mothers with children with cystic fibrosisIRCT20240501061617N1Ahvaz University of Medical Sciences56
已完成
不适用
Comparison of blood pressure control by CLAPS with manual control in patients undergoing elective cardiac surgeryCTRI/2018/01/011487PGIMER Chandigarh40
已完成
不适用
Study to evaluate the effectiveness and saftyof the mFOLFOX+bevacizumab combination therapy for bladder adenocarcinomabladder adenocarcinomaJPRN-UMIN000021193agoya City University Hospital2